These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)--an in vivo metabolite of PGE1 in man. Ney P; Braun M; Szymanski C; Bruch L; Schrör K Eicosanoids; 1991; 4(3):177-84. PubMed ID: 1663381 [TBL] [Abstract][Full Text] [Related]
7. [The pharmacology of 13,14-dihydro-PGE1 in comparison with PGE1]. Braun M; Ney P; Hohlfeld T; Szymanski C; Bruch L; Schrör K Vasa Suppl; 1991; 33():337-8. PubMed ID: 1788747 [TBL] [Abstract][Full Text] [Related]
8. Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation. Pallapies D; Peskar BA Thromb Res; 1993 Aug; 71(3):217-25. PubMed ID: 8211888 [TBL] [Abstract][Full Text] [Related]
9. The induction of cyclooxygenase-2 elicited by endotoxin in endothelial cells and macrophages is inhibited by prostaglandin E1 and 13,14-dihydro prostaglandin E1. Akarasereenont P; Hide E; Ney P; Thiemermann C; Vane JR Agents Actions Suppl; 1995; 45():59-64. PubMed ID: 7717202 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjects. Cawello W; Schweer H; Müller R; Bonn R; Seyberth HW Eur J Clin Pharmacol; 1994; 46(3):275-7. PubMed ID: 8070511 [TBL] [Abstract][Full Text] [Related]
11. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease. Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896 [TBL] [Abstract][Full Text] [Related]
12. Interindividual variation in the enzymatic 15-keto-reduction of 13,14-dihydro-15-keto-prostaglandin E1 in human liver and in human erythrocytes. Rady-Pentek P; Mueller R; Tang BK; Kalow W Eur J Clin Pharmacol; 1997; 52(2):147-53. PubMed ID: 9174685 [TBL] [Abstract][Full Text] [Related]
13. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease]. Hesse WH; Rudofsky G; Peskar BA Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222 [TBL] [Abstract][Full Text] [Related]
14. On the metabolism of prostaglandin E1 administered intravenously to human volunteers. Peskar BA; Cawello W; Rogatti W; Rudofsky G J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892 [TBL] [Abstract][Full Text] [Related]
15. PGE0 inhibits collagen and glycosaminoglycan-synthesis in the rabbit arterial wall. Rodrigues M; Sinzinger H; Kritz H; Peskar BA; O'Grady J; Rogatti W Vasa; 1995; 24(4):333-6. PubMed ID: 8533442 [TBL] [Abstract][Full Text] [Related]
16. Determination of prostaglandin E1 and its main plasma metabolites 15-keto-prostaglandin E0 and prostaglandin E0 by gas chromatography/negative ion chemical ionization triple-stage quadrupole mass spectrometry. Schweer H; Meese CO; Watzer B; Seyberth HW Biol Mass Spectrom; 1994 Mar; 23(3):165-70. PubMed ID: 8148408 [TBL] [Abstract][Full Text] [Related]
17. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells. Oliva D; Bernini F; Corsini A; Nicosia S Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney. Schwertschlag U; Stahl T; Hackenthal E Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776 [TBL] [Abstract][Full Text] [Related]